Filter By Category
Archives
Share on -
Galicaftor
Generic Name: galicaftor
Small molecule CFTR modulator/corrector candidate
ABSTRACT
galicaftor is a small-molecule agent with class-specific pharmacology: Small molecule CFTR modulator/corrector candidate. The therapeutic or diagnostic role depends on its target pathway and clinical indication.
DOSAGE
Dose and schedule depend on indication, formulation, patient factors, and label/trial protocol. Do not extrapolate dosing across related drugs.
SIDE EFFECTS
- Gastrointestinal upset or headache
- Rash or hypersensitivity
- Laboratory abnormalities depending on target organ
- Class-specific infection, metabolic, or hepatic effects
ALLERGIC REACTIONS
These symptoms may indicate an allergic or hypersensitivity reaction and require medical attention.
- Urticaria, generalized rash, or pruritus
- Angioedema of lips, tongue, throat, or face
- Bronchospasm, dyspnea, wheezing, or chest tightness
- Anaphylaxis or severe infusion/injection reaction
DRUG INTERACTIONS
- Review CYP, transporter, and renal/hepatic interactions
- Avoid duplicative class therapy unless directed
- Immunosuppressive drugs may increase infection risk
- Concomitant disease therapy may require dose adjustment
PRECAUTIONS
- Monitor organ function and target-specific biomarkers
- Assess pregnancy, allergy, and comorbidities
- Use protocol-specific stopping rules
- Counsel patients on expected adverse effects
WARNINGS
- Severe hypersensitivity or target-specific toxicity may occur
- Use only in the indicated population and with monitoring
Share on -
. Developed by